3 transcripts
CRVS
Earnings call transcript
NASDAQ
2024 Q2
6 Aug 24
and Severity Index score, also known as EASI, and the Investigator Global Assessment.
The first cohort, which utilizes the lowest soquelitinib dose of 100
CRVS
Earnings call transcript
NASDAQ
2024 Q1
6 May 24
follow-up assessments. In the most recent data cutoff from May 3, 2024, we had 2 additional patients that achieved an objective response at their first
CRVS
Earnings call transcript
NASDAQ
2023 Q4
19 Mar 24
assessment and the clinically validated measurement of improvement in Eczema Area and Severity Index, also known as EASI, E-A-S-I. It should be noted
- Prev
- 1
- Next